Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-54.76%Return on Equity
VS
Market
Sector
Industry
History
$ 2.7Close
$ 1.41 - $ 4 52-Week Range
Ticker Information
Ticker
FBIOCompany Name
FORTRESS BIOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQFORTRESS BIOTECH INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
FBIO - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 43.92M | $ -24.05M | -54.76% |
| 3/31/2025 | $ 22.25M | $ -50.75M | -228.07% |
| 12/31/2024 | $ 22.74M | $ -55.89M | -245.81% |
| 9/30/2024 | $ 21.16M | $ -57.4M | -271.28% |
| 6/30/2024 | $ 17.88M | $ -49.41M | -276.39% |
| 3/31/2024 | $ 23.02M | $ -62.85M | -272.99% |
| 12/31/2023 | $ 22.54M | $ -68.67M | -304.6% |
| 9/30/2023 | $ 16.67M | $ -82.32M | -493.71% |
| 6/30/2023 | $ 18.51M | $ -97.78M | -528.28% |
| 3/31/2023 | $ 37.8M | $ -92.35M | -244.34% |
Key Performance Insights, Last 5 Years
- FORTRESS BIOTECH INC's latest trailing twelve months (TTM) ROE stands at -58.41%.
- Over the past 5 years, FORTRESS BIOTECH INC's average ROE has been -187.09%.
- The median ROE for FORTRESS BIOTECH INC during this period was -177.69%
- FORTRESS BIOTECH INC reached its highest ROE over the past 5 years at -30.66%.
- The lowest ROE recorded by FORTRESS BIOTECH INC in the same timeframe -528.28%
FORTRESS BIOTECH INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for FORTRESS BIOTECH INC is calculated as follows: Net Inc. Cmn. [ $ -56.72M ] / Equity [ $ 97.11M ]
(=) ROE [ -58.41% ] FBIO - Return on Equity, Last 5 years
-528.28%
Minimum
Jun 30, 2023
-30.66%
Maximum
Jun 30, 2021
-187.09%
Average
-177.69%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |